Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
R-21-GA202
- Development stage
- Unknown
- Lead developer
- Dong-A Pharmaceutical
- Modality
- Small Molecules
- Administration
- Topical, Buccal
01
Overview
R-21-GA202 is a consumer healthcare product developed by Dong-A Pharmaceutical for the maintenance and improvement of oral hygiene. As of 2024, the candidate is in the registration phase (NDA/BLA), indicating it has completed its primary clinical development and is undergoing regulatory review for commercialization. While the specific chemical composition is not publicly detailed in pipeline disclosures, the product is positioned within Dong-A's research center portfolio for oral care, a sector where the company holds a significant market presence with its Garglin brand. R-21-GA202 is intended for topical application within the oral cavity, likely functioning as an antimicrobial or protective formulation to prevent common dental and periodontal issues such as plaque accumulation and gingivitis.
- Other names
- R-21-GA202R21-GA202R 21-GA202IR-2024-001IR2024-001IR 2024-001
Beyond the preview
Go deeper on R-21-GA202.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on R-21-GA202.